These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8831212)

  • 1. [Urodynamic evaluation of alpha-1 blocker tamsulosin on benign prostatic hyperplasia using pressure-flow study].
    Miyatake R; Park YC; Koike H; Ohnishi N; Sugiyama T; Kurita T; Esa A; Kiwamoto H
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1048-55. PubMed ID: 8831212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder.
    Kakizaki H; Ameda K; Kobayashi S; Tanaka H; Shibata T; Koyanagi T
    Int J Urol; 2003 Nov; 10(11):576-81. PubMed ID: 14633081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS].
    Ohtani M; Kikuchi K; Tsuchiya A; Noguchi R; Akaza H; Kondo F; Koiso K
    Hinyokika Kiyo; 2000 Nov; 46(11):791-7. PubMed ID: 11193299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand.
    Arnold EP
    BJU Int; 2001 Jan; 87(1):24-30. PubMed ID: 11121988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial.
    Djavan B; Shariat S; Fakhari M; Ghawidel K; Seitz C; Partin AW; Roehrborn CG; Marberger M
    Urology; 1999 Feb; 53(2):251-9. PubMed ID: 9933035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamsulosin for the treatment of benign prostatic hypertrophy.
    Lee M
    Ann Pharmacother; 2000 Feb; 34(2):188-99. PubMed ID: 10676828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: prospective pressure-flow study.
    Wada N; Kita M; Hashizume K; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2013 Nov; 32(8):1123-7. PubMed ID: 23861329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Mac Donald R; Rutks I
    Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of novel urodynamic parameters, detrusor contraction duration and detrusor contraction index, in men with lower urinary tract symptoms.
    Turner CD; Kuznetsov D; Contreras BA; Gerber GS
    Tech Urol; 1998 Sep; 4(3):136-40. PubMed ID: 9800891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia].
    Hayashi T; Sakai Y; Saito K; Arai G; Hyochi N; Suzuki M; Masuda H; Kawakami S; Okuno T; Kobayashi T; Kageyama Y; Kihara K
    Hinyokika Kiyo; 2002 Jan; 48(1):7-11. PubMed ID: 11868386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition zone ratio and prostate-specific antigen density as predictors of the response of benign prostatic hypertrophy to alpha blocker and anti-androgen therapy.
    Kurita Y; Masuda H; Suzuki K; Fujita K; Kawabe K
    Br J Urol; 1997 Jul; 80(1):78-83. PubMed ID: 9240185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of doxazosin efficacy in the treatment of the benign prostatic enlargement].
    Aganović D; Aganović K; Prcić A
    Med Arh; 2004; 58(3):153-6. PubMed ID: 15484855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only].
    Ueki O; Kawaguchi K; Katsumi T; Murayama K; Kameda K; Nishino A; Sakai A; Haginaka T; Miyazaki K; Asari T; Egawa M
    Hinyokika Kiyo; 1998 Aug; 44(8):565-73. PubMed ID: 9783192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia with overactive bladder].
    Kosugi S; Ikemoto I; Furuta A; Shimomura T; Kiyota H; Suzuki Y; Kishimoto K; Egaway S; Torii S; Shirai H; Takeuchi H; Abe K
    Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):691-9. PubMed ID: 17682448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction.
    Nagabukuro H; Hashimoto T; Iwata M; Doi T
    BJU Int; 2005 May; 95(7):1071-6. PubMed ID: 15839935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and urodynamic results of alpha-blocker drug treatment in patients with lower urinary tract symptoms and benign prostatic hyperplasia].
    Salinas J;
    Arch Esp Urol; 2015 Mar; 68(2):161-71. PubMed ID: 25774823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
    Martorana G; Giberti C; Di Silverio F; von Heland M; Rigatti P; Colombo R; Casadei G; Pacifico P
    Eur Urol; 1997; 32(1):47-53. PubMed ID: 9266231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.